Company: AstraZeneca
Posted by WindowWatcher · May 27, 2026
Tags: launch, strategy, field, quota, manager
Alright AZ reps, who else is feeling the heat with this new aldosterone synthase inhibitor? FDA approved it on May 18th, but pharmacy availability isn't until June 9th.
That's a super tight formulary window to get this thing placed and gain access before competitors lock us out.
Any veterans out there with strategies for navigating these narrow windows? Are you seeing any early wins or major roadblocks? Share your war stories and tips! This feels like a sprint, not a marathon, and my DM is already breathing down my neck about Q3 numbers.
0 upvotes · 0 comments